Prostate News and Research

RSS

Study highlights role of patient maximizing-minimizing preferences in thyroid cancer surveillance

Not all patients feel the same way about medical treatment. Some are "minimizers," preferring to see a doctor as little as possible and to give health issues a chance to resolve on their own. Others are "maximizers" who want to treat a disease to the fullest extent possible, even if doesn't make a big difference in the overall outcome.

14 Oct 2019

New microfluidic test can detect Lyme disease within 15 minutes

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications.

11 Oct 2019

More sensitive electrophysiology tools needed to study cancer cell populations

Bioelectricity of Cancer, a special issue of the peer-reviewed journal Bioelectricity, has just been published. Two promising discoveries are well delineated: an ultra-sensitive tool to detect cancer and a new therapeutic target for cancer immunotherapy.

9 Oct 2019

Lab-grown, testosterone-producing cells could help treat hypogonadism

Researchers have managed to grow human, testosterone-producing cells, which could lead to improved treatment options for low testosterone levels.

9 Oct 2019

Statin use linked with lower risk of developing prostate cancer

In a study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer.

9 Oct 2019

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primary cancer.

8 Oct 2019

New insight into meningioma - possibility of targeted therapy

A new study published in the journal Oncotarget shows that certain mutations in the brain tumor called meningioma may help identify patients who have a better chance of recovery. This could help physicians make better clinical decisions based on more accurate diagnoses. It has also unveiled some of the genes that go wrong in meningiomas, as well as showing how targeted therapy could one day help fight this tumor.

7 Oct 2019

Study shows association between mushroom consumption and lower risk of prostate cancer

Results from the first long-term cohort study of more than 36,000 Japanese men over decades suggest an association between eating mushrooms and a lower risk of prostate cancer.

7 Oct 2019

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.

7 Oct 2019

Research provides new insights into tumorigenesis of meningioma

The identification of oncogenic mutations has provided further insights into the tumorigenesis of meningioma and the possibility of targeted therapy.

5 Oct 2019

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

3 Oct 2019

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.

3 Oct 2019

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

A research team from the Johns Hopkins Kimmel Cancer Center reports it has discovered a metabolic vulnerability in multiple types of cancer cells that bear a common genetic mutation affecting cellular machines called spliceosomes.

From Johns Hopkins Medicine 3 Oct 2019

Gut bacterial profile can predict gut damage following radiotherapy

Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine.

3 Oct 2019

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene.

3 Oct 2019

Prostate News and Research

Study highlights role of patient maximizing-minimizing preferences in thyroid cancer surveillance

New microfluidic test can detect Lyme disease within 15 minutes

More sensitive electrophysiology tools needed to study cancer cell populations

Lab-grown, testosterone-producing cells could help treat hypogonadism

Statin use linked with lower risk of developing prostate cancer

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

New insight into meningioma - possibility of targeted therapy

Study shows association between mushroom consumption and lower risk of prostate cancer

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Research provides new insights into tumorigenesis of meningioma

Multi-gene testing at point of diagnosis can save all women with breast cancer

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

Gut bacterial profile can predict gut damage following radiotherapy

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

Targeted therapy slows disease progression and improves survival for prostate cancer

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Men with prostate cancer can be spared postoperative radiotherapy

High-dose radiation effective for men whose prostate cancer has spread, trial shows

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News